Ira Pastor

Progress, Potential, and Possibilities Podcast / Show

Science EN ↓ 875 episodes

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

Author

Ira Pastor

Category

Science

Podcast website

www.youtube.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Courtney Barriger - Founder, Holding Court - Reimagining Fashion 30.08.2025

Send us Fan Mail Courtney Barriger ( https://www.courtneybarriger.com/ ) is a fashion expert, sustainability advocate, writer, and entrepreneur who has dedicated her career to reimagining the way we create and consume clothing. After building a successful career in the fashion world, Courtney shifted her focus to tackling the urgent environmental and ethical issues caused by fast fashion. She has...

Warren Roberts - CEO, Living Legacy Forest - Returning To Earth & Living On Through Nature 25.08.2025

Send us Fan Mail Warren Roberts is CEO and Founder of Living Legacy Forest ( https://livinglegacyforest.com/ ), an innovative profit-for-purpose company and leader in green memorialization reforestation, which is creating urban memorial forests by turning human (and pet) ashes into trees and living memorial forests, instead of cemeteries, with the ultimate goal of reforesting the planet. With the...

Dr. Jacob Lalezari, MD - CEO, CytoDyn - Next Generation of Monoclonal Antibody Therapeutics 21.08.2025

Send us Fan Mail Dr. Jacob Lalezari, MD is the Chief Executive Officer of CytoDyn ( https://www.cytodyn.com/ ), a biopharma company committed to enhancing the lives of patients through target specific medicine and a next generation of monoclonal antibody therapeutics. CytoDyn’s team is focused on developing leronlimab, a monoclonal antibody CCR5 receptor antagonist, to be used as a platform drug f...

Dr. Reynold Panettieri, MD - Rutgers University - Novel Therapeutic Approaches To Treat Airways Diseases 07.08.2025

Send us Fan Mail Dr. Reynold A. Panettieri, Jr, MD ( https://ritms.rutgers.edu/faculty/reynold-panettieri/ ) is the inaugural Director of the Institute for Translational Medicine and Science, and Vice Chancellor for Translational Medicine and Science, at Rutgers University, and previously served as the Director of the Airways Biology Initiative at the University of Pennsylvania.  Dr. Panettieri’s...

Alex Reed - President & CCO, Yokogawa Fluence Analytics - Smart Polymer Manufacturing 07.08.2025

Send us Fan Mail Alex Reed is a Co-founder, President and CCO of Yokogawa Fluence Analytics ( https://www.fluenceanalytics.com/ ), a manufacturer of systems that produce continuous data streams enabling real-time optimization of manufacturing and R&D processes. The company, formerly known as Fluence Analytics, is a division of the Yokogawa Electric Corporation ( https://www.yokogawa.com/ ). Pr...

Dr. Paul Jaffe, Ph.D. - Tactical Technology Office, DARPA - Power Beaming and Space Solar 02.08.2025

Send us Fan Mail Dr. Paul Jaffe, Ph. D. ( https://www.darpa.mil/about/people/paul-jaffe ) is a Program Manager in DARPA’s Tactical Technology Office, where he oversees the Persistent Optical Wireless Energy Relay ( POWER - https://www.darpa.mil/research/programs/power ) project, which aims to revolutionize energy distribution through airborne wireless power transfer, enabling high power beaming, r...

Martin Burns - CEO, Bruin Biometrics - Early Detection And Prevention Of Pressure Injuries 31.07.2025

Send us Fan Mail Martin Burns is the CEO of Bruin Biometrics, a platform company focused on digital solutions for pressure injury prevention and management, where since 2012 he has designed and led the successful journey of Bruin Biometrics’ Provizio SEM Scanner ( https://sem-scanner.com/) through the company’s concept-to-commercialization “formulas strategy”. Significant milestones along the way...

Jason Matuszewski - CEO, BioStem Technologies - Saving Limbs To Save Lives 30.07.2025

Send us Fan Mail Jason Matuszewski is Chief Executive Officer and Chairman of the Board of BioStem Technologies ( https://biostemtechnologies.com/ ), a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.  Jason brings a wealth of experience in strategic operations plannin...

Dr. Luis Pizarro, MD - Executive Director, DNDi - The Best Science For The Most Neglected Patients 30.07.2025

Send us Fan Mail Dr. Luis Pizarro, MD is Executive Director of the Drugs for Neglected Diseases initiative ( DNDi - https://dndi.org/ ), the international, not-for-profit research and development organization focused on discovering, developing, and delivering affordable and patient-friendly treatments for neglected patients around the world. Dr. Pizarro is a medical doctor and global health leader...

Dr Ashwin Gopinath, PhD - CTO, Biostate AI - Transforming Healthcare Through Next-Gen RNAseq & GenAI 30.07.2025

Send us Fan Mail Dr. Ashwin Gopinath, Ph. D. ( https://ashwingopinath.com/ ) is Co-Founder and CTO of Biostate AI ( https://biostate.ai/ ), a startup building generative AI that predicts the evolution of human disease and drug response based on RNA sequencing data. Its patented wet lab technologies, including BIRT (Barcode-Integrated Reverse Transcription), allow affordable and scalable collection...

Bill Taranto - President, Merck Global Health Innovation Fund - Scaling Impactful Innovation 28.07.2025

Send us Fan Mail Bill Taranto is President of the Merck Global Health Innovation Fund ( MGHIF - https://www.msdghifund.com/ ). The Merck Global Health Innovation Fund was established in late 2010 as a strategic response to the challenges surrounding Merck’s core business of discovering, developing and marketing innovative drugs and vaccines. Bill has more than three decades of experience in the he...

Dr. On-Yee (Amy) Lo - Marcus Institute for Aging Research - Functional Independence For Older Adults 24.07.2025

Send us Fan Mail Dr. On-Yee (Amy) Lo, Ph. D. is Assistant Scientist II at the Marcus Institute for Aging Research ( https://www.marcusinstituteforaging.org/who-we-are/profiles/yee-amy-lo-phd ) and Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center ( https://connects.catalyst.harvard.edu/Profiles/display/Person/147630 ). Dr. Lo is a physical therapist a...

George Vradenburg - Founding Chairman, Davos Alzheimer’s Collaborative - Advancing Brain Health 24.07.2025

Send us Fan Mail George Vradenburg is Founding Chairman of the Davos Alzheimer's Collaborative ( DAC - https://www.davosalzheimerscollaborative.org/ ), a pioneering worldwide initiative to prevent Alzheimer’s disease, seeking to mirror the success of global efforts against infectious diseases. DAC is extending global research beyond its current focus on traditional Western European ethnic pop...

Dr. Lara Nyman, Ph.D. - VP, Research & Discovery, AG1 - Clinically Backed Foundational Nutrition 22.07.2025

Send us Fan Mail Dr. Lara Nyman, Ph. D. is the Vice President of Research & Discovery at AG1 ( https://drinkag1.com/learn/research/scientific-research ), responsible for leading the company's innovative research efforts to develop cutting-edge nutritional products. In this role, she oversees the research and development of new formulations, ensures the scientific integrity of product clai...

Pedro Sanchez de Lozada - CEO, Canid - Streamlining Pediatric Vaccine Management 19.07.2025

Send us Fan Mail Pedro Sanchez de Lozada is Co-Founder and CEO of Canid ( https://www.canid.io/ ), a company which is modernizing every aspect of providing vaccines in pediatrics, from operations, to finances, to maximizing care. Canid focuses the details of executing a vaccine program so that pediatricians can instead focus on the children.  Pedro is a seasoned CEO with a background in early-stag...

Dr. Marc Salzberg, MD - CEO, Airway Therapeutics - Novel Biologics For Severe Respiratory Diseases 17.07.2025

Send us Fan Mail Dr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases. Dr. Salzberg has more than 25 years of academic and pharmaceutic...

Paul Keable - CSO, Ashley Madison - Technology, Culture And Future Relationships 16.07.2025

Send us Fan Mail Paul Keable is Chief Strategy Officer at Ashley Madison ( https://www.ashleymadison.com/ ) - the global online dating and social networking platform, specifically catering to individuals in committed relationships seeking discreet connections. As Chief Strategy Officer, Paul oversees the strategic direction of Ashley Madison, emphasizing discretion, authenticity, and innovation wi...

William Ho - CEO, IN8bio - Next Generation Cell Therapies For Cancer 14.07.2025

Send us Fan Mail William Ho is a Co-Founder, and has served as the President, Chief Executive Officer, and Director of IN8bio ( https://in8bio.com/ ), a biotech company with a mission of developing next-generation therapies for treating cancer, with a focus on gamma-delta T cells, since its inception.    Mr. Ho has worked in the biotechnology industry for nearly 24 years.  Prior to the founding of...

Dr. Thomas Ehmer, Ph.D. - Merck KGaA Darmstadt, Germany - Quantum Computing Innovation In Pharma 10.07.2025

Send us Fan Mail Dr. Thomas Ehmer, Ph. D.  ( https://www.linkedin.com/in/tehmer/ ) is a seasoned technology strategist with over two decades of experience in IT innovation, business development, and R&D within the pharmaceutical industry, and co-founder of the Quantum Interest Group, at Merck KGaA Darmstadt, Germany ( https://www.emdgroup.com/en ).  Dr. Ehmer currently is in the Sector Data Of...

Josh Haimson - CEO, Inductive Bio - Democratizing AI To Transform Drug Discovery 08.07.2025

Send us Fan Mail Josh Haimson is Co-Founder and CEO of Inductive Bio ( https://www.inductive.bio/about ), a technology company focused on democratizing artificial intelligence (AI) models to transform small molecule drug discovery, eliminating Absorption, Distribution, Metabolism, Excretion and Toxicology (ADMET) bottlenecks with state-of-the-art AI models and generative chemistry, powered by a un...

Dr. Shai Melcer, Ph.D. - Head, National Bioconvergence Program, Israel Innovation Authority - Advancing Israel's Bioconvergence Future 07.07.2025

Send us Fan Mail Dr. Shai Melcer, Ph. D. is Head of the National Bioconvergence Program ( https://bioconvergence.org.il/ ) at the Israel Innovation Authority ( https://innovationisrael.org.il/en/ ). In this role, Dr. Melcer, who brings 15 years of experience and entrepreneurship in the bio-medical ecosystem, leads the implementation of the bioconvergence goals for TELEM – the National Infrastructu...

Dr. Robert Schwab, MD - Penn Medicine - CAR-T In Cardiovascular Medicine 03.07.2025

Send us Fan Mail Dr. Robert Schwab, MD is a Resident Physician, Research Specialist, and Hematology-Oncology Fellow at Penn Medicine, University of Pennsylvania Health System ( https://www3.pennmedicine.org/departments-and-centers/department-of-medicine/divisions/hematology-and-oncology/education-and-training/hematology-oncology-fellowship/fellows ). Dr. Schwab’s work to date has focused on leukem...

Dr. Frank Bedu-Addo, Ph.D. - CEO, PDS Biotech - Transforming How The Immune System Fights Disease 02.07.2025

Send us Fan Mail Dr. Frank Bedu-Addo, Ph. D. has served as a director, president and CEO of PDS Biotech ( https://pdsbiotech.com/ ) since its inception in 2005, a biotech company focused on transforming how the immune system targets and fights disease by developing a new generation of targeted cancer treatments. Dr. Bedu-Addo is a veteran biotech executive with experience successfully starting and...

Daniel Schmitt - President & CEO, Actuate Therapeutics - Targeting Hard-To-Treat Cancers 02.07.2025

Send us Fan Mail Daniel Schmitt is President & Chief Executive Officer of Actuate Therapeutics, Inc. ( https://actuatetherapeutics.com/ ), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β). Mr. Schmitt brings over 30 years of successful indust...

Fiona Cauley & Dr. David Lynch - Division of Neurology at Children's Hospital of Philadelphia (CHOP) and Director of the Friedreich's Ataxia Program - Comedy, Biotech Research & Patient Advocacy 01.07.2025

Send us Fan Mail Fiona Cauley ( https://www.fionacauley.com ) is a Nashville-based comedy superstar who uses her comedy for a greater purpose – to raise awareness about her rare, genetic disease, Friedreich's Ataxia (FA), that progressively damages the nervous system, causing loss of muscle control over time, and is found in approximately one in 50,000 people worldwide (5,000 individuals in t...

Listen to the Progress, Potential, and Possibilities Podcast / Show podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.